<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01071785</url>
  </required_header>
  <id_info>
    <org_study_id>HCPA-06370</org_study_id>
    <nct_id>NCT01071785</nct_id>
  </id_info>
  <brief_title>Dietetic Intervention With Soluble Fiber in Type 2 Diabetes Mellitus (DM) Patients With Metabolic Syndrome (MS)</brief_title>
  <official_title>Dietetic Intervention With Soluble Fiber in Type 2 Diabetes Mellitus (DM) Patients With Metabolic Syndrome (MS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metabolic Syndrome (MS) is an clinical condition with high cardiovascular risk. More than 80%
      of DM patients had MS. Dietary factors can be associated to both, DM and MS. Therefore the
      aim of this study is to evaluate the effects of add soluble fiber (goma-guar) in the usual
      diet of type 2 DM with MS and compare this intervention with an usual diet without this
      supplement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study was to evaluate the effect of soluble fiber (guar gum) on the MS
      components (International Diabetes Federation-2005 and WHO): blood pressure, plasma glucose,
      triglycerides, HDL, central obesity (waist, BMI),and albuminuria. Secondary objectives are:
      effect of guar gum on serum fatty acids, , PCR, endothelin 1, and fibrinogen. Primary
      outcomes were alterations on MS components.

      Forty-four type 2 diabetic outpatients were included in a randomized clinical trial:
      treatment 1- guar gum (10g/day) + usual diet; treatment 2- usual diet. The duration of each
      treatment was six weeks. Three days weight diet records with concurrent 24h urinary
      collections (protein intake estimative), clinical and laboratory evaluation were performed at
      baseline and after 4 and 6 weeks. Serum fatty acids were measured in total triglycerides
      fractions by gas chromatography.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes on the components of metabolic syndrome (according to IDF and WHO criteria): blood pressure, waist, body mass index (BMI), triglycerides, high-density lipoprotein (HDL) cholesterol, glucose values (HBA1c) and urinary albumin excretion.</measure>
    <time_frame>4 and 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes on serum fatty acids and serum cholesterol</measure>
    <time_frame>4 and 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Albuminuria</condition>
  <arm_group>
    <arm_group_label>usual diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no dietary or drug intervention. Patients followed their usual diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>guar gum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>guar gum</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>guar gum</intervention_name>
    <description>guar gum 10g/day for six weeks</description>
    <arm_group_label>guar gum</arm_group_label>
    <other_name>benefiber; guar gum group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with type 2 diabetes

          -  Using metformin and/or Insulin

        Exclusion Criteria:

          -  serum triglycerides &gt; 400 mg/dl

          -  serum creatinine &gt; 2 mg/dl

          -  gastrointestinal malabsorption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mirela J Azevedo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HCPA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorge L Gross, MD</last_name>
    <role>Study Director</role>
    <affiliation>HCPA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valesca Dall'Alba, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HCPA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HCPA</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90630040</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2008</study_first_submitted>
  <study_first_submitted_qc>February 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2010</study_first_posted>
  <last_update_submitted>February 25, 2010</last_update_submitted>
  <last_update_submitted_qc>February 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 1, 2010</last_update_posted>
  <responsible_party>
    <name_title>Mirela jobim de Azevedo</name_title>
    <organization>Federal University of Rio GRAnde do sul</organization>
  </responsible_party>
  <keyword>Metabolic Syndrome</keyword>
  <keyword>diet</keyword>
  <keyword>fiber</keyword>
  <keyword>Serum lipids</keyword>
  <keyword>Albuminuria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Albuminuria</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

